Viewing StudyNCT01305239



Ignite Creation Date: 2024-05-05 @ 11:19 PM
Last Modification Date: 2024-10-26 @ 10:32 AM
Study NCT ID: NCT01305239
Status: TERMINATED
Last Update Posted: 2012-04-10
First Post: 2011-02-24

Brief Title: A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane Aromasin In Postmenopausal Hr Patients
Sponsor: Pfizer
Organization: Pfizer

Organization Data

Organization: Pfizer
Class: INDUSTRY
Study ID: NRA5990024
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Pfizer
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators